Immunotherapy of Nivolumab with Dendritic Cell Vaccination Is Effective against Intractable Recurrent Primary Central Nervous System Lymphoma: A Case Report
Methodology
content missing
Therapy
content missing
Results
content missing
Conclusion
content missing
